The Journal of Infectious Diseases · 1981 · 155 citations · 18 references
Life SciencesPharmacokineticsPharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceBacteriologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibiotic ResistanceBacterial InfectionsBeta-lactam ResistancePharmacokinetics Of AntimicrobialsAntibiotic Susceptibility TestingBactericidal AgentsCerebrospinal Fluid SystemGram-positive Bacterial InfectionsSpectrum Of Beta-lactam Antibioticsβ-Lactam Antibiotics
The pharmacokinetics and bacteriologic efficacy of four beta-lactam antibiotics were studied in the serum and cerebrospinal fluid (CSF) of rabbits using two test strains, Escherichia coli type K1 and group B Streptococcus type III, and 24 gram-positive isolates. Although moxalactam, cefotaxime, cefoperazone, and rocephin are active in vitro against gram-negative bacilli, the gram-positive bacteria Listeria monocytogenes and Streptococcus faecalis were resistant to all four drugs; group B streptococci were resistant to moxalactam. In rabbit CSF, moxalactam had the greatest concentration and penetration, but rocephin had the longest half-life and duration of bactericidal activity. These two drugs were most effective in the CSF of E. coli K1-infected rabbits. Except for moxalatam, the four drugs were comparable to ampicillin in reducing counts of group B Streptococcus type III in CSF. Drug accumulation in CSF and appreciable bacterial killing were observed in E. coli K1-infected animals give moxalactam either periodically or by constant infusion.
18
Wendell H. Hall, Bonnie J. Opfer, Dale N. Gerding · Antimicrobial Agents and Chemotherapy · 1980 · 94 citations · Full text
Michael Barza, Francis P. Tally, N V Jacobus et al. · Antimicrobial Agents and Chemotherapy · 1979 · 93 citations · Full text